Congress approved an $8.3 billion package to fight the spread of coronavirus and respond to the growing crisis.

Despite international travel interruptions due to COVID-19, HIMSS20 is moving “full steam ahead as scheduled” for March 9 to 13 in Orlando.

AI technology could play a vital rule in the diagnosis and treatment of aggressive posterior retinopathy of prematurity (AP-ROP) in infants, according to new research published in Ophthalmology.

SymphonyAI Group, a private group of companies specializing in AI, announced Wednesday, March 4, that it has acquired TeraRecon. No financial details have been shared at this time.

Augmented reality (AR) technology could play a pivotal role in the interventional radiology (IR) suite of the future, according to a new study published in the Journal of Vascular and Interventional Radiology.

The healthcare industry has voiced its support and pushback after the FTC sued to block a merger between two hospital systems in Philadelphia.

AI-powered smart bandages could soon be used to treat severe wounds, monitoring the healing process and delivering various stimuli when appropriate.

A probable carcinogen NDMA has been found in a diabetes drug metformin, testing by a pharmacy has confirmed. The FDA previously announced it was testing metformin, which helps control blood sugar, for NDMA.

“Alexa, what is Tylenol?” Amazon’s cloud-based voice service can now answer health questions like this after partnering up with a drug and medical device knowledge company.

Proscia, a Philadelphia-based AI technology company, has partnered with the University of California, San Francisco (UCSF) to improve cancer diagnoses and patient outcomes.